UnitedHealth Group Incorporated (UNH)
You Can Spell UnitedHealth Without AI
UnitedHealth delivered a Q3 double beat and raised full-year guidance, signaling improving cost efficiency despite ongoing sector-wide margin pressures. UNH remains undervalued due to sector headwinds and lack of AI narrative, yet its scale, pricing power, and resilient business model offer long-term upside. Optum's restructuring and disciplined capital management position UNH for margin restoration and sustainable growth, with operational gains already visible.
UnitedHealth's Q3 earnings report shows turnaround efforts are gaining steam
UnitedHealth on Tuesday raised its annual profit forecast and said it aims to grow in 2026, in a sign that the turnaround efforts under new CEO Stephen Hemsley were gaining steam.
UnitedHealth Earnings Top Expectations, as Insurer Works Toward a Turnaround
America's biggest insurer is showing some signs of improvement in the health of its business, after a series of setbacks.
UnitedHealth Boosts Guidance And Eyes Big 2026
UnitedHealth beat EPS expectations and raised full-year guidance, signaling early signs of stabilization.
UnitedHealth raises full-year guidance as Q3 earnings beat estimates
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) reported third-quarter revenue and adjusted earnings per share that beat Wall Street expectations, driven by growth in its health benefits and pharmacy services, and raised its full-year guidance. Revenue rose 12% from a year earlier to $113.2 billion, narrowly above analysts' estimate of $113.16 billion.
Insurance Stock Drifts Lower After Revenue Miss
Shares of UnitedHealth Group Inc (NYSE:UNH) were last seen down 0.5% to trade at $364.11, after the company announced third-quarter results of $2.92 per share on $113.2 billion in revenue, the former beating estimates and the latter falling short.
UnitedHealth: Nothing Is Over
UnitedHealth Group Incorporated delivered Q3 revenue of $113.2 billion, up 12.3% year-over-year, slightly ahead of consensus estimates despite ongoing regulatory and cost challenges. UNH's Q3 EPS of $2.92 beat expectations, signaling stabilization, while the medical care ratio remained elevated at 89.9% but in line with forecasts. Management raised 2025 guidance, expecting adjusted EPS of at least $16.25 and total revenues around $447 billion, with Optum Rx as a key growth driver.
UnitedHealth (UNH) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
UnitedHealth Revenue Rises as Turnaround Efforts Continue
For the third quarter, UnitedHealth reported adjusted earnings per share of $2.92 compared with $7.15 a year earlier. Revenue rose to $113.2 billion from $100.8 billion.
UnitedHealth's Moment of Truth: 3 Bullish Signals to Watch For
UnitedHealth Group NYSE: UNH has staged a formidable comeback, with its stock up over 29% in the last 90 days as investors embraced management's aggressive turnaround strategy. This powerful rally has built high expectations, and the market now looks to UnitedHealth Group's third-quarter earnings report on Oct. 28 for the proof needed to sustain the momentum.
What's Behind The 30% Surge In UNH Stock?
UnitedHealth (UNH)'s stock jumped 31% in three months, driven not only by a slight increase in revenue and a high P/E multiple, but also amid mixed signals: a Q2 earnings miss, regulatory scrutiny, and renewed investments in AI. What's behind this volatility?
Analysts Estimate UnitedHealth Group (UNH) to Report a Decline in Earnings: What to Look Out for
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
